J. Levin-allerhand et al., Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments, J NEUROCHEM, 79(4), 2001, pp. 796-803
Cerebral apolipoprotein E (apoE) has been implicated in neuronal protection
and repair. Dub to the variable levels and types of estrogen receptors wit
hin different brain regions, the effect of estrogen on apoE and the mechani
sm of this effect may vary within different regions. Ovariectomized female
C57BL/6 mice were treated with pharmacological levels of 17 beta -estradiol
or placebo for 5 days, resulting in supraphysiological plasma levels of es
tradiol in the treated mice. ApoE and glial fibrillary acidic protein (GFAP
) levels were measured in the cortex, hippocampus and diencephalon. 17 beta
-Estradiol up-regulated apoE but not GFAP in the cortex and diencephalon,
whereas in the hippocampus, GFAP and apoE were equally up-regulated. Treatm
ent of estrogen receptor (ER) knockout mice with 17 beta -estradiol or trea
tment of C57BL/6 mice with 17 alpha -estradiol, a poor estrogen receptor ag
onist, specifically induced apoE in the cortex, but not in the diencephalon
. These results indicate that 17 beta -estradiol effects on apoE are either
directly or indirectly mediated by ER alpha in the diencephalon, while the
effects in the cortex may be mediated by a non-classical mechanism or by E
R beta. Measurement of mRNA levels in estrogen versus placebo-treated wildt
ype mice indicated that the effect of 17 beta -estradiol on apoE was not as
sociated with changes in apoE mRNA levels.